ARCH Venture Partners IX Overage, L.P.
Reporting owner on Forms 3, 4 and 5, CIK 1723172.
- In the filer group ARCH Venture Partners XII, LLC
ARCH Venture Partners IX Overage, L.P. reported on 1 issuer in 2 filings, the latest a 13D/A filed 2026-11-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| LYEL · Lyell Immunopharma, Inc.CIK 1806952 | 10% owner | 1 | 2026-11-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| LYEL · Lyell Immunopharma, Inc.Common Stock | 2026-11-04 | P bought | +2,321,262 | $10.77 | 3,747,790 | Form 4 |
| LYEL · Lyell Immunopharma, Inc.Common Stock, holding | 910,317 | Form 4 | ||||
| LYEL · Lyell Immunopharma, Inc.Common Stock, holding | 910,317 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13D/A 0001012975-26-001020 | VIR | 2026-11-06 | ||
| Form 4 0001012975-26-001014 | Lyell Immunopharma, Inc. | 2026-11-05 |